You can check out the annual or quarterly balance sheets of Genenta Science SPA here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025H2

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021Q4

FY2021Q2

Total equity

Cash, cash equivalents and short-term investments

141.20%33.06M

-32.79%11.69M

-25.47%15.63M

-35.85%17.40M

-39.74%20.97M

--27.12M

--34.80M

--35.45M

--9.35M

- Cash and cash equivalents

30.87%6.49M

23.73%4.23M

-50.39%5.72M

-87.39%3.42M

-66.87%11.53M

--27.12M

--34.80M

--35.45M

--9.35M

-Short-term investments

203.78%26.57M

-46.62%7.46M

4.97%9.91M

--13.98M

--9.44M

----

Receivables

-4.85%1.53M

-27.38%1.37M

-39.23%1.13M

29.36%1.89M

-2.94%1.86M

--1.46M

--1.91M

--1.41M

--973.70K

-Accounts and notes receivable

-50.65%19.23K

5.19%33.24K

2.66%31.83K

-15.62%31.60K

-12.72%31.01K

--37.45K

--35.53K

--55.23K

--0.00

Prepaid expenses

75.52%224.24K

-68.89%108.98K

-43.40%179.21K

271.78%350.36K

-51.39%316.61K

--94.24K

--651.34K

--38.30K

--68.58K

Other current assets

73.62%396.32K

225.02%194.73K

34934.50%229.20K

-70.00%59.91K

-99.64%654.21

--199.69K

--181.36K

--0.00

--331.01K

Total current assets

124.70%35.21M

-32.13%13.37M

-25.83%17.17M

-31.79%19.69M

-38.36%23.14M

--28.87M

--37.54M

--36.90M

--10.73M

Non-current assets

Net Fixed Assets

-43.22%26.39K

-48.43%39.64K

-40.34%57.97K

-24.34%76.88K

46.86%97.17K

--101.61K

--66.17K

--21.98K

--18.26K

-Fixed Assets

14.33%174.85K

2.94%130.46K

-0.34%128.16K

12.48%126.73K

59.94%128.59K

--112.66K

--80.40K

--28.45K

--21.80K

-Accumulated depreciation

39.46%148.46K

82.19%90.81K

123.37%70.19K

350.97%49.85K

120.73%31.42K

--11.05K

--14.24K

--6.46K

--3.53K

Other non-current assets

-72.75%5.29K

-91.51%16.57K

-88.99%22.51K

405.20%195.10K

5981.47%204.47K

--38.62K

--3.36K

--3.19K

--3.70K

Total non-current assets

490.20%2.24M

-67.92%324.20K

-80.16%413.88K

-35.30%1.01M

139.14%2.09M

--1.56M

--872.42K

--1.21M

--1.05M

Total assets

133.36%37.45M

-33.87%13.69M

-30.32%17.58M

-31.97%20.71M

-34.32%25.23M

--30.43M

--38.42M

--38.11M

--11.78M

Liabilities

Current liabilities

-Other payables

-12.16%492.50K

21.20%478.32K

80.95%583.34K

-3.61%394.65K

-19.27%322.38K

--409.45K

--399.34K

--119.73K

--149.93K

Accrued expenses

-83.75%222.32K

24.14%1.17M

-13.12%886.41K

49.36%940.16K

83.09%1.02M

--629.47K

--557.23K

--803.94K

--1.09M

Other current liabilities

-12.16%492.50K

21.20%478.32K

80.95%583.34K

-3.61%394.65K

-19.27%322.38K

--409.45K

--399.34K

--119.73K

--149.93K

Total current liabilities

9.44%2.49M

20.58%1.94M

10.32%1.84M

-19.08%1.61M

38.74%1.67M

--1.99M

--1.21M

--1.08M

--1.48M

Non-current liabilities

Long-term provisions

56.11%384.98K

37.90%210.37K

48.54%181.52K

88.41%152.56K

120.62%122.20K

--80.97K

--55.39K

--29.15K

--19.18K

Long-term debt and lease liabilities

--8.93M

--0.00

-Long-term debt

--8.93M

----

Employee benefits

56.11%384.98K

37.90%210.37K

48.54%181.52K

88.41%152.56K

120.62%122.20K

--80.97K

--55.39K

--29.15K

--19.18K

Other non-current liabilities

55.32%384.98K

27.31%211.44K

33.00%188.90K

57.06%166.08K

61.55%142.03K

--105.74K

--87.92K

--29.15K

--19.18K

Total non-current liabilities

3658.10%9.31M

27.31%211.44K

33.00%188.90K

57.06%166.08K

61.55%142.03K

--105.74K

--87.92K

--29.15K

--19.18K

Total liabilities

368.18%11.80M

21.21%2.15M

12.09%2.03M

-15.24%1.77M

40.29%1.81M

--2.09M

--1.29M

--1.11M

--1.50M

Shareholders' equity

Common equity

33.51%98.96M

1.34%63.23M

-0.87%62.72M

2.93%62.40M

-4.66%63.27M

--60.62M

--66.36M

--62.72M

--32.91M

Retained earnings

-21.12%-73.51M

-18.53%-51.77M

-18.72%-47.31M

-35.32%-43.68M

-36.30%-39.85M

---32.28M

---29.24M

---25.72M

---22.63M

Capital reserves

----

--0.00

Gains losses not affecting retained earnings

103.08%195.57K

-61.64%82.15K

--139.37K

--214.16K

----

Total equity

89.60%25.65M

-39.04%11.54M

-33.61%15.55M

-33.20%18.93M

-36.92%23.42M

--28.34M

--37.12M

--37.00M

--10.28M

Currency unit

--USD

Audit opinions

----

FAQs

Which balance sheet metrics matter most when analyzing GNTA stock?



Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?



Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?



Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does Genenta Science SPA Have?



In its most recent quarterly, Genenta Science SPA had 6.49M in cash and cash equivalents.

How Much Are Genenta Science SPA's Total Liabilities?



Genenta Science SPA reported 11.64M in total liabilities as of the latest reported quarter, including 2.45M in current liabilities and 9.19M in non-current liabilities.

What Are Genenta Science SPA's Total Assets?



As of the latest reported quarter, Genenta Science SPA's total assets were 36.95M, consisting of 34.74M in current assets and 2.21M in non-current assets.

How Much Shareholders' Equity Does Genenta Science SPA Have?



Genenta Science SPA reported 25.31M in total shareholders' equity as of the latest reported quarter.